Ex vivo expansion of HIV type 1-specific cytolytic T cells from HIV type 1-seropositive subjects

J. Lieberman, J. A. Fabry, P. Shankar, Laurel A Beckett, P. R. Skolnik

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Cytotoxic T lymphocytes that specifically lyse HIV-1-infected cells occur at uncommonly high frequency in the blood of infected individuals. The CTL response is dominated by the recognition of a small number of peptides encoded by HIV-1 structural and regulatory genes. These two facts have enabled us to develop potent HIV-specific CTL lines from the blood of infected patients without AIDS opportunistic infections by ex vivo culture of nonspecifically stimulated T cell lines with autologous antigen-presenting cells (APCs) preincubated with immunodominant HIV-1 peptides. After one selection, HIV-specific cytotoxicity is enhanced 1.4-to sixfold. Frequency analysis of the T cell line from 1 patient revealed that after exposure to peptide-incubated autologous B-LCLs, the frequency of CTLs specific for the gp160-expressing APCs was enhanced 6-fold and, after a second exposure, 11- fold compared to the nonselected T cell line. Because the APCs used for the frequency analysis were EBV-transformed B-LCLs, some of the specific CTLs in the culture recognized the EBV-expressing APCs. HIV-specific cytotoxicity is enhanced without augmentation of EBV-specific cytotoxicity when PBMCs are used as APCs. Because T cell lines enhanced for HIV-1 specificity are highly cytotoxic and can be expanded to approximately 109-1010 cells/ml of blood, they may be useful for laboratory research or for immunotherapy.

Original languageEnglish (US)
Pages (from-to)257-271
Number of pages15
JournalAIDS Research and Human Retroviruses
Volume11
Issue number2
StatePublished - 1995
Externally publishedYes

Fingerprint

Antigen-Presenting Cells
HIV-1
T-Lymphocytes
Human Herpesvirus 4
Cell Line
HIV
Peptides
Opportunistic Infections
Autoantigens
Cytotoxic T-Lymphocytes
Regulator Genes
Immunotherapy
Blood Cells
Acquired Immunodeficiency Syndrome
Research

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this

Ex vivo expansion of HIV type 1-specific cytolytic T cells from HIV type 1-seropositive subjects. / Lieberman, J.; Fabry, J. A.; Shankar, P.; Beckett, Laurel A; Skolnik, P. R.

In: AIDS Research and Human Retroviruses, Vol. 11, No. 2, 1995, p. 257-271.

Research output: Contribution to journalArticle

Lieberman, J. ; Fabry, J. A. ; Shankar, P. ; Beckett, Laurel A ; Skolnik, P. R. / Ex vivo expansion of HIV type 1-specific cytolytic T cells from HIV type 1-seropositive subjects. In: AIDS Research and Human Retroviruses. 1995 ; Vol. 11, No. 2. pp. 257-271.
@article{1c7e82bc7a3e40fa8424a00e3f4d7b52,
title = "Ex vivo expansion of HIV type 1-specific cytolytic T cells from HIV type 1-seropositive subjects",
abstract = "Cytotoxic T lymphocytes that specifically lyse HIV-1-infected cells occur at uncommonly high frequency in the blood of infected individuals. The CTL response is dominated by the recognition of a small number of peptides encoded by HIV-1 structural and regulatory genes. These two facts have enabled us to develop potent HIV-specific CTL lines from the blood of infected patients without AIDS opportunistic infections by ex vivo culture of nonspecifically stimulated T cell lines with autologous antigen-presenting cells (APCs) preincubated with immunodominant HIV-1 peptides. After one selection, HIV-specific cytotoxicity is enhanced 1.4-to sixfold. Frequency analysis of the T cell line from 1 patient revealed that after exposure to peptide-incubated autologous B-LCLs, the frequency of CTLs specific for the gp160-expressing APCs was enhanced 6-fold and, after a second exposure, 11- fold compared to the nonselected T cell line. Because the APCs used for the frequency analysis were EBV-transformed B-LCLs, some of the specific CTLs in the culture recognized the EBV-expressing APCs. HIV-specific cytotoxicity is enhanced without augmentation of EBV-specific cytotoxicity when PBMCs are used as APCs. Because T cell lines enhanced for HIV-1 specificity are highly cytotoxic and can be expanded to approximately 109-1010 cells/ml of blood, they may be useful for laboratory research or for immunotherapy.",
author = "J. Lieberman and Fabry, {J. A.} and P. Shankar and Beckett, {Laurel A} and Skolnik, {P. R.}",
year = "1995",
language = "English (US)",
volume = "11",
pages = "257--271",
journal = "AIDS Research and Human Retroviruses",
issn = "0889-2229",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - Ex vivo expansion of HIV type 1-specific cytolytic T cells from HIV type 1-seropositive subjects

AU - Lieberman, J.

AU - Fabry, J. A.

AU - Shankar, P.

AU - Beckett, Laurel A

AU - Skolnik, P. R.

PY - 1995

Y1 - 1995

N2 - Cytotoxic T lymphocytes that specifically lyse HIV-1-infected cells occur at uncommonly high frequency in the blood of infected individuals. The CTL response is dominated by the recognition of a small number of peptides encoded by HIV-1 structural and regulatory genes. These two facts have enabled us to develop potent HIV-specific CTL lines from the blood of infected patients without AIDS opportunistic infections by ex vivo culture of nonspecifically stimulated T cell lines with autologous antigen-presenting cells (APCs) preincubated with immunodominant HIV-1 peptides. After one selection, HIV-specific cytotoxicity is enhanced 1.4-to sixfold. Frequency analysis of the T cell line from 1 patient revealed that after exposure to peptide-incubated autologous B-LCLs, the frequency of CTLs specific for the gp160-expressing APCs was enhanced 6-fold and, after a second exposure, 11- fold compared to the nonselected T cell line. Because the APCs used for the frequency analysis were EBV-transformed B-LCLs, some of the specific CTLs in the culture recognized the EBV-expressing APCs. HIV-specific cytotoxicity is enhanced without augmentation of EBV-specific cytotoxicity when PBMCs are used as APCs. Because T cell lines enhanced for HIV-1 specificity are highly cytotoxic and can be expanded to approximately 109-1010 cells/ml of blood, they may be useful for laboratory research or for immunotherapy.

AB - Cytotoxic T lymphocytes that specifically lyse HIV-1-infected cells occur at uncommonly high frequency in the blood of infected individuals. The CTL response is dominated by the recognition of a small number of peptides encoded by HIV-1 structural and regulatory genes. These two facts have enabled us to develop potent HIV-specific CTL lines from the blood of infected patients without AIDS opportunistic infections by ex vivo culture of nonspecifically stimulated T cell lines with autologous antigen-presenting cells (APCs) preincubated with immunodominant HIV-1 peptides. After one selection, HIV-specific cytotoxicity is enhanced 1.4-to sixfold. Frequency analysis of the T cell line from 1 patient revealed that after exposure to peptide-incubated autologous B-LCLs, the frequency of CTLs specific for the gp160-expressing APCs was enhanced 6-fold and, after a second exposure, 11- fold compared to the nonselected T cell line. Because the APCs used for the frequency analysis were EBV-transformed B-LCLs, some of the specific CTLs in the culture recognized the EBV-expressing APCs. HIV-specific cytotoxicity is enhanced without augmentation of EBV-specific cytotoxicity when PBMCs are used as APCs. Because T cell lines enhanced for HIV-1 specificity are highly cytotoxic and can be expanded to approximately 109-1010 cells/ml of blood, they may be useful for laboratory research or for immunotherapy.

UR - http://www.scopus.com/inward/record.url?scp=0028939440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028939440&partnerID=8YFLogxK

M3 - Article

C2 - 7742040

AN - SCOPUS:0028939440

VL - 11

SP - 257

EP - 271

JO - AIDS Research and Human Retroviruses

JF - AIDS Research and Human Retroviruses

SN - 0889-2229

IS - 2

ER -